Endovia Health Sciences, Inc.
EDVA
New York Stock Exchange Arca0.16
USD
+0.00
- -
Endovia Health Sciences, Inc.
EDVA
(New York Stock Exchange Arca)
Recent
price
0.16
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Endovia Health Sciences, Inc. is a biomedical technology company that develops and commercializes advanced health science solutions focused on translational research, diagnostics, and therapeutic delivery platforms. The company designs, manufactures, and distributes a portfolio of proprietary instruments, consumables, and software that enable rapid, scalable, and precise health outcomes across research institutions, healthcare providers, and biopharmaceutical partners. Core product families include in vitro diagnostic kits, molecular assays, and related automation systems for clinical and research laboratories; modular nanomedicine and drug-delivery platforms for targeted therapies; and data analytics software that supports real-time monitoring, decision support, and regulatory-compliant reporting. The firm integrates hardware, software, and service components to provide end-to-end solutions for biomarker discovery, translational research, clinical diagnostics, and personalized medicine. Latest major company changes include strategic partnerships and collaborations with academic medical centers and biotechnology companies to co-develop and validate diagnostic and therapeutic platforms; an active series of fundraising rounds to expand manufacturing capacity and accelerate pipeline development; the acquisition of complementary diagnostics and assay developers to broaden product offerings; and organizational reorganizations to align product lines with core market verticals. In the past 1–2 years, Endovia Health Sciences, Inc. undergoes expansion of manufacturing footprint and distribution capabilities to support global commercialization, along with launches of new diagnostic assays and targeted delivery technologies. Industry and business segments span life sciences instrumentation, molecular diagnostics, nanomedicine, and health data analytics. Target customers include academic and research institutions, clinical laboratories, biotechnology and pharmaceutical companies, and healthcare networks seeking translational research support, companion diagnostic development, and precision medicine solutions. Geographic operations encompass the United States, Europe, and select Asia-Pacific markets, with manufacturing and R&D activities primarily based in North America and Europe. The company operates through subsidiaries and maintains parent-subsidiary relationships to coordinate research, development, manufacturing, and commercial distribution. Founding year and headquarters location are disclosed by corporate disclosures and public filings.
Company News
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways